Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ARX contributors: mct/pgu - updated : 08-02-2014
HGNC name aristaless related homeobox
HGNC id 18060
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • two independent repression domains: an N-terminal octapeptide motif/engrailed homology domain, necessary for Groucho-dependent repression activity
  • a high overall GC content of 72.5p100 that codes for a multidomain protein, including the octapeptide domain, that binds DNA
  • three nuclear localization sequences
  • four polyalanine tracts (pA1-4)
  • two repression domains, the OP and a second domain located in the C-terminus at amino acids (398-448) of the protein, termed ORD (for other repression domain)
  • C-terminal Aristaless domain, a novel octapeptide motif/engrailed homology domain, and four polyalanine (polyA) tracts, and missense mutations in the ARX homeodomain represent loss-of-function mutations, which lead to a reduced or complete loss of DNA binding and as a consequence, a loss of transcriptional repression
  • HOMOLOGY
    interspecies ortholog to murine Arx
    Homologene
    FAMILY
  • paired homeobox family
  • bicoid subfamily
  • CATEGORY transcription factor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus
    text restricted to regions that are known to be rich in GABAergic neurons
    basic FUNCTION
  • playing a role in the differentiation, radial and tangential migration and maintenance of specific neuronal subtypes in the cerebral cortex (crucial for the development of cognitive function) and a secondary role in the differentiation of the testes (controlling the function of Leydig cells)
  • acting as a novel positive regulator of embryonic myogenesis by synergizing with MEF2C and MYOD1 and by establishing an activating loop with myogenin
  • can function as a transcriptional repressor
  • important for many developmental processes, including proper migration of GABA-ergic cortical interneurons and neuronal cell differentiation and proliferation, and for proper pancreatic endocrine cell specification through the inhibition of PAX4
  • plays multiple roles in forebrain development, both dependent and independent of DLX1/2
  • may play a role in controlling cell cycle exit of neural progenitors within the subpallium
  • not directly involved in GABAergic cell fate specification, but having multiple and distinct cell-autonomous roles for ARX in corticogenesis
  • required for the normal development of human enteroendocrine cells, and in the progenitor for enteroendocrine cell development
  • CELLULAR PROCESS cell life, differentiation
    nucleotide, transcription
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with IPO13 (with the C-terminal nuclear localization sequences in the homeodomain of ARX is required for correct nuclear localization)
  • interaction between ARX and the co-repressors Groucho and CtBP
  • EBF3, LMO1 and SHOX2 are direct transcriptional targets of ARX (can bind to the putative enhancers of EBF3, LMO1 and SHOX2)
  • genetic interactions between NKX2-2 and ARX within the endocrine progenitor cells that ensure the correct specification and regulation of endocrine hormone-producing cells
  • LMO1 and SHOX2, are ARX targets (mutations in the ARX homeodomain disrupt repression of LMO1 and SHOX2, direct targets of ARX transcription repression)
  • KDM5C is directly regulated by ARX through the binding in a conserved noncoding element (ARX transactivates the 5prime KDM5C regulatory element by binding to the two “TAAT/ATTA” boxes (BD1 and BD2)
  • ARX is a direct target of NKX6.1
  • LHX6 directly binds to an ARX enhancer and to an intronic CXCR7 enhancer that remains active in mature interneurons
  • EBF3 is a downstream transcriptional target of aristaless-related homeobox (ARX) and is thought to be transcriptionally repressed by ARX
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) ISSX , PRTS , XLAG , MRX54 , EIEE1
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS